Literature DB >> 21289000

31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients.

Harmen Reyngoudt1, Koen Paemeleire, Benedicte Descamps, Yves De Deene, Eric Achten.   

Abstract

BACKGROUND: Differences in brain energy metabolism have been found between migraine patients and controls in previous phosphorus magnetic resonance spectroscopy ((31)P-MRS) studies, most of them emphasizing migraine with aura (MwA). The aim of this study was to verify potential changes in resting-state brain energy metabolism in patients with migraine without aura (MwoA) compared to control subjects by (31)P-MRS at 3 tesla.
METHODS: Quantification was performed using the phantom replacement technique. MRS measurements were performed interictally and in the medial occipital lobe of 19 MwoA patients and 26 age-matched controls.
RESULTS: A significantly decreased phosphocreatine concentration ([PCr]) was found as in previous studies. While adenosine triphosphate concentration ([ATP]) was considered to be constant in previously published work, this study found a significant decrease in the measured [ATP] in MwoA patients. The inorganic phosphate ([P(i)]) and magnesium ([Mg(2+)]) concentrations were not significantly different between MwoA patients and controls.
CONCLUSIONS: The altered metabolic concentrations indicate that the energy metabolism in MwoA patients is impaired, certainly in a subgroup of patients. The actual decrease in [ATP] adds further strength to the theory of the presence of a mitochondrial component in the pathophysiology of migraine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289000     DOI: 10.1177/0333102410394675

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  24 in total

Review 1.  Pain as an evolutionary necessity.

Authors:  V Bonavita; R De Simone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 2.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 3.  Brain Energy Deficit as a Source of Oxidative Stress in Migraine: A Molecular Basis for Migraine Susceptibility.

Authors:  Jonathan M Borkum
Journal:  Neurochem Res       Date:  2021-04-30       Impact factor: 3.996

Review 4.  The Evidence for the Role of Nutraceuticals in the Management of Pediatric Migraine: a Review.

Authors:  Serena L Orr
Journal:  Curr Pain Headache Rep       Date:  2018-04-04

Review 5.  Advanced Imaging in the Evaluation of Migraine Headaches.

Authors:  Benjamin M Ellingson; Chelsea Hesterman; Mollie Johnston; Nicholas R Dudeck; Andrew C Charles; Juan Pablo Villablanca
Journal:  Neuroimaging Clin N Am       Date:  2019-02-19       Impact factor: 2.264

Review 6.  Structural and Functional Brain Changes in Migraine.

Authors:  Sait Ashina; Enrico Bentivegna; Paolo Martelletti; Katharina Eikermann-Haerter
Journal:  Pain Ther       Date:  2021-02-16

Review 7.  The metabolic face of migraine - from pathophysiology to treatment.

Authors:  Elena C Gross; Marco Lisicki; Dirk Fischer; Peter S Sándor; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2019-10-04       Impact factor: 42.937

8.  Volumetric brain changes in migraineurs from the general population.

Authors:  Inge H Palm-Meinders; Enrico B Arkink; Hille Koppen; Souad Amlal; Gisela M Terwindt; Lenore J Launer; Mark A van Buchem; Michel D Ferrari; Mark C Kruit
Journal:  Neurology       Date:  2017-10-11       Impact factor: 9.910

Review 9.  The Role of Metabolism in Migraine Pathophysiology and Susceptibility.

Authors:  Olivia Grech; Susan P Mollan; Benjamin R Wakerley; Daniel Fulton; Gareth G Lavery; Alexandra J Sinclair
Journal:  Life (Basel)       Date:  2021-05-01

10.  Irradiation induced injury reduces energy metabolism in small intestine of Tibet minipigs.

Authors:  Yu-Jue Wang; Wen Liu; Chi Chen; Li-Meng Yan; Jun Song; Kun-Yuan Guo; Gang Wang; Qing-Hong Wu; Wei-Wang Gu
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.